APP and Alzheimer disease: In this context, the consistent repression of PARK2 and its associated decrease in presenilin1/γ-secretase expression/activity observed in all models examined by De Bastiani and colleagues would yield enhanced levels of C99, in agreement with our C99-centric etiological hypothesis for AD.